Synthesis and properties of dextran-5-aminosalicylic acid ester as a potential colon-specific prodrug of 5-aminosalicylic acid

被引:35
作者
Jung, YJ [1 ]
Lee, JS [1 ]
Kim, HH [1 ]
Kim, YT [1 ]
Kim, YM [1 ]
机构
[1] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea
关键词
dextran-5-aminosalicylic acid ester; colon-specific delivery; 5-aminosalicylic acid; Crohn's disease; ulcerative colitis; inflammatory bowel disease;
D O I
10.1007/BF02974025
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dextran-5-aminosalicylic acid ester (dextran-5-ASA) was synthesized as a colon-specific prodrug of 5-aminosalicylic acid (5-ASA) which is active against inflammatory bowel diseases. Chemical stability of dextran-5-ASA in the bath of pH 1.2 or 6.8 was investigated at 37 degrees C for 6 hrs, and 5-ASA was not released on such conditions. Depolymerization (%) of dextran-5-ASA by dextranase with the degree of substitution (DS) of 18, 23, or 30 was 92, 62 or 45 in 8 hrs respectively, but was not affected by the MW of dextran (9,000, 40,600, 80,200 or 580,000). Distribution of 5-ASA in dextran, determined by gel filtration chromatography, appeared to be relatively uniform. Incubation of dextran-5-ASA (DS 18) in cecal contents of rats released 20% (28 g) and 35% (49 g) of 5-ASA in 8 hrs and 24 hrs, respectively, but no 5-ASA was liberated from small intestinal contents.
引用
收藏
页码:179 / 186
页数:8
相关论文
共 25 条
[1]  
Andrew DM, 1992, ORAL COLON SPECIFIC, P213
[2]  
ASHORE M, 1993, J CONTROL RELEASE, V26, P213
[3]  
BRONDSTED H, 1995, STP PHARMA SCI, V5, P60
[4]   SOLUBLE FUNCTIONAL POLYMERS .3. A POLYMERIC DRUG FOR TREATMENT OF INFLAMMATORY BOWEL-DISEASE [J].
BROWN, JP ;
MCGARRAUGH, GV ;
PARKINSON, TM ;
WINGARD, RE ;
ONDERDONK, AB .
JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (09) :1300-1307
[5]   A SIMPLE AND RAPID LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF MAJOR METABOLITES OF SULFASALAZINE IN BIOLOGICAL-FLUIDS [J].
CHUNGI, VS ;
REKHI, GS ;
SHARGEL, L .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (03) :235-237
[6]   DRUG-THERAPY OF ULCERATIVE-COLITIS [J].
CROTTY, B ;
JEWELL, DP .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (03) :189-198
[7]  
ENGLYST HN, 1987, FEMS MICROBIOL ECOL, V45, P163, DOI 10.1016/0378-1097(87)90013-9
[8]  
HAEBERLINE B, 1992, ORAL COLON SPECIFIC, P27
[9]  
ISTRAN C, 1991, MAGY KEM FOLY, V97, P143
[10]  
JUNG YJ, UNPUB YAKHAK HOEJI